CAS-CLOVER Clinical Trials

All | CRISPR-Cas | TALEN | ZFN | MegaNuclease | megaTAL | Base Editor

Antibacterial

Blood

Cancer

Solid Tumors, (NCT05239143)
Sponsors:
Poseida Therapeutics 
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Multiple Myeloma, MM, (NCT04960579)
Sponsors:
Poseida Therapeutics, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory B-cell Malignancies, (NCT06014762)
Sponsors:
Poseida Therapeutics, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III

Eye

Metabolic disorder

Other genetic conditions

close
Search CRISPR Medicine